The level of miR-16 inversely correlates with NF-κB 1 protein expression, and miR-16 directly reduces the expression of the NF-κB 1 protein, inhibiting glioma cell invasion through the NF-κB/MMP9 signaling pathway [88]. Here, NFKB1 is linked to central nervous system cancer.